Abstract:Objective To evaluate the relationship between fragile histidine triad(FHIT) transcription abnormalities and HPV16 infection and human cervical tumorigenesis.Methods Total RNA from 5 cervical carcinoma cell lines(SiHa,HeLa,RJC-1,CS1213 and C4-1),58 primary cervical cancer specimens and 18 normal cervical epithelial tissues were extracted and FHIT transcripts were characterized by a two-step(nested) reverse transcription(RT)-PCR.The seven of the PCR products with different size were purified and sequenced.HPV16 infection was assessed by PCR.Results ① There were altered FHIT transcripts in SiHa,HeLa and C4-1 cells.Aberrant FHIT transcripts were detected in 39 out of the 58 cervical cancer samples(67.2%),but none out of 18 in the normal cervix tissue specimens(0%);HPV16 infections were identified in 37 of the 58 cervical cancer tissues(63.8%),but 1 in the 18 normal cervical epithelial tissues(5%),which showed a significant difference between these two groups(P<0.05).② The number of partial deletions of the FHIT gene in the group with HPV16 infection(29/37) was significantly higher than that in the group without HPV16 infection(9/21) and the correlation was found between aberration of FHIT transcript and HPV16 infection.There was no obvious difference in age,stage,tumor size,grade and lymph node metastasis between the groups with and without FHIT abnormalities and HPV16 infection(P>0.05).③ The exon 5 and exon 6 were mainly deleted in the altered FHIT transcripts and no insertion and point mutation were found by DNA sequencing.Conclusion Aberrant FHIT expression was significantly common in cervical cancers and was correlated with HPV16 infection.These findings suggest that the tumor suppressor gene FHIT and high risk HPV16 may play a very important role in human cervical carcinogenesis.

Detection of Fragile Histindine Triad Protein in Cutis Squamous Cell Carcinoma and Its Clinical Significance

Loss of fragile histidine triad gene expression in papillary thyroid carcinoma

Expression of Fragile Histidine Triad in Primary Hepatocellular Carcinoma and Its Relation with Cell Proliferation and Apoptosis

Clinicopathological Significance of Expression of Fragile Histidine Triad Protein in Neuroendocrine Lung Carcinoma

Detection and Significance of Abnormality FHIT Gene Exons in Cutis Primary T Cell Lymphoma

The Expression of FHIT Protein in Progression of Breast Carcinoma

Use of High-Risk Human Papiilomavirus DNA Testing to Deal with Atypical Squamous Cells-Can-not Exclude HSIL

Expression of FHIT Protein in Primary Carcinoma of the Gallbladder and Its Significance.

Expression of FHIT Protein,ki-67 and Their Significance in Endometrial Carcinoma

The significance of FHIT gene detection for the diagnosis of lung cancer in transbronchial biopsy tissue samples and sputum samples

Fragile histidine triad transcription abnormalities and human papillomavirus16 infection in human cervical carcinoma

The Significance and Relationship Between the Expressions of FHIT Gene and HER_2 in Non-Small Cell Lung Cancer

Correlation Between Tripartite Motif-Containing Protein 44 Protein Expression and the Prognosis of Postoperative Patients Exhibiting Skin Squamous Cell Carcinoma

The Significance of STAT3 and MAPK Phosphorylation and Cyclind1 Protein Expression in Skin Squamous Cell Carcinoma

Effect of interventional embolotherapy on FHIT and p16 expression in hepatocellular carcinoma patients

Study of mRNA Expressions of FHIT Genes in Patients with Non- small Cell Lung Cancer

Loss of FHIT protein expression is a marker of adverse evolution in good prognosis localized breast cancer

Detection Of Human Telomerase Rna Gene In Cervical Cancer And Precancerous Lesions Comparison With Cytological And Human Papillomavirus Dna Test Findings

Association of the promoter methylation and protein expression of Fragile Histidine Triad (FHIT) gene with the progression of differentiated thyroid carcinoma.

Promoter methylation and expression of fragile histidine triad gene gene in papillary thyroid carcinoma

The Clinicopathological Significance and Drug Target Potential of FHIT in Breast Cancer, a Meta-Analysis and Literature Review.